Dr. Kenneth C. Anderson

Dr. Kenneth C. Anderson, MD, is an internationally recognized medical oncologist specializing in hematologic malignancies, with a particular focus on multiple myeloma. He serves as the Kraft Family Professor of Medicine at Harvard Medical School and Director of the Lebow Institute for Myeloma Therapeutics and the Jerome Lipper Multiple Myeloma Center at Dana-Farber Cancer Institute. Dr. Anderson earned his medical degree from Johns Hopkins University School of Medicine and completed residency training in internal medicine at Johns Hopkins Hospital, followed by fellowship training in hematology and oncology at Dana-Farber Cancer Institute. He is board-certified in Internal Medicine, Hematology, and Medical Oncology and is widely regarded for his transformative leadership in myeloma research and treatment.

A pioneer in translational science, Dr. Anderson has made seminal contributions to understanding the biology of myeloma, particularly the role of the bone marrow microenvironment in disease progression and drug resistance. His laboratory discoveries directly contributed to the development and FDA approval of novel therapies, including proteasome inhibitors and immunomodulatory agents, which have dramatically improved outcomes for patients with multiple myeloma. He has led national and international clinical trials that have defined new standards of care and authored over 500 peer-reviewed publications. His leadership has been central to the evolution of precision medicine approaches in hematologic oncology.

Beyond his research achievements, Dr. Anderson is a devoted educator and mentor, training generations of oncologists and physician-scientists who now lead myeloma research worldwide. He has served in leadership roles for the American Society of Hematology (ASH), the American Society of Clinical Oncology (ASCO), and the International Myeloma Society. He is an elected member of the Institute of Medicine of the National Academy of Sciences and has received numerous prestigious awards for his contributions to cancer research. Through his commitment to discovery, innovation, and mentorship, Dr. Kenneth C. Anderson continues to shape the global landscape of myeloma care and research.